This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slipped 8.82% to $7.55 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.57% to 4,443.05 and Dow Jones Industrial Average falling 0.84% to 34,577.57. Ocugen Inc. closed $11.22 below its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Adverum Biotechnologies Inc. (ADVM) fell 4.41% to $2.17, Ocular Therapeutix Inc. (OCUL) fell 1.56% to $10.70, and Kodiak Sciences Inc. (KOD) fell 0.47% to $93.91. Trading volume (21.6 M) eclipsed its 50-day average volume of 14.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2021.
(END) Dow Jones Newswires
September 14, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.